Citation Impact

Citing Papers

Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
2008
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Telomere analysis by fluorescence in situ hybridization and flow cytometry
1998
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
Essential role of mouse telomerase in highly proliferative organs
1998 StandoutNatureNobel
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
2009
Stem Cell Transplantation for Indolent Lymphoma and Chronic Lymphocytic Leukemia
2010
Modular regulatory principles of large non-coding RNAs
2012 StandoutNature
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant
2005
hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization
1997 Standout
Processive Utilization of the Human Telomerase Template
2004 StandoutNobel
Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma
2007
Telomere states and cell fates
2000 StandoutNatureNobel
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
1997 StandoutNobel
Functionally interacting telomerase RNAs in the yeast telomerase complex
1997 StandoutNobel
The Hallmarks of Cancer
2000 Standout
Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy
2009
Vascular disorders of the liver # †
2008 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation
2004
The mouse telomerase RNA 5'-end lies just upstream of the telomerase template sequence
1998 StandoutNobel
Secondary Structure of Vertebrate Telomerase RNA
2000 StandoutNobel
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation
2008
Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis
1996 StandoutNobel
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
1999 StandoutNobel
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
Hematopoietic Stem-Cell Transplantation
2006 Standout
A survey of telomerase activity in human cancer
1997 Standout
Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates
1996
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 StandoutNobel
Switching and Signaling at the Telomere
2001 StandoutNobel
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Development of Retinoblastoma in the Absence of Telomerase Activity
1996
Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse
1999 StandoutNobel
Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell Transplantation
2007
Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On†
2010
Creation of human tumour cells with defined genetic elements
1999 StandoutNature
Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation†
2005
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation
2003
Telomere elongation in immortal human cells without detectable telomerase activity.
1995
Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas
1996
Telomerase Activity in Reactive and Neoplastic Lymphoid Tissues: Infrequent Detection of Activity in Hodgkin's Disease
1997
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients
2003
Tetrahymena proteins p80 and p95 are not core telomerase components
2001 StandoutNobel
Rap1 protein regulates telomere turnover in yeast
1998 StandoutNobel
Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
1999 StandoutNobel
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Acute Myeloid Leukemia
2015 Standout
Telomerase activity, cell proliferation, and cancer
1998 StandoutNobel
The rate of telomere sequence loss in human leukocytes varies with age
1998 StandoutNobel
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Ku is associated with the telomere in mammals
1999 StandoutNobel
Alterations in p53 and p16INK4 Expression and Telomere Length during Spontaneous Immortalization of Li-Fraumeni Syndrome Fibroblasts
1995
A Trypanosoma brucei Protein Complex That Binds G-overhangs and Co-purifies with Telomerase Activity
2002 StandoutNobel
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
1997 StandoutScienceNobel
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents.
1996
TELOMERES AND TELOMERASE IN HUMAN CANCER (REVIEW)
1995
Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes.
1996
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
2003
Telomerase in kinetoplastid parasitic protozoa
1999 StandoutNobel
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Telomerase activity in normal leukocytes and in hematologic malignancies
1995
Telomerase RNA mutations in Saccharomyces cerevisiae alter telomerase action and reveal nonprocessivity in vivo and in vitro.
1997 StandoutNobel
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation
2001 StandoutNobel
Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase.
1996 StandoutNobel
The RNA Component of Human Telomerase
1995 StandoutScienceNobel
Effects of Reverse Transcriptase Inhibitors on Telomere Length and Telomerase Activity in Two Immortalized Human Cell Lines
1996 StandoutNobel
Multiple Myeloma
2011 Standout
Late Effects of Hematopoietic Cell Transplantation Among 10-Year Adult Survivors Compared With Case-Matched Controls
2005
A functional telomerase RNA swap in vivo reveals the importance of nontemplate RNA domains
1997 StandoutNobel
Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention
2003
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
1998 StandoutScience

Works of Kari Remes being referenced

Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience
2006
Spontaneous remission in acute myeloid leukaemia
1994
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group
1998
Prognostic Factors in Autologous Stem Cell Transplantation for Multiple Myeloma: An EBMT Registry Study
1994
Treatment of Multiple Myeloma with All-Trans Retinoic Acid Alone and in Combination with Chemotherapy: a Phase I/II Trial
2003
Bone mineral density after allogeneic bone marrow transplantation
1999
The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spine
1995
Telomerase activity in vivo in human malignant hematopoietic cells.
1994
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation
2002
Rankless by CCL
2026